South Dakota Investment Council’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-400
Closed -$11K 587
2021
Q2
$11K Sell
400
-9,000
-96% -$220K ﹤0.01% 577
2021
Q1
$220K Sell
9,400
-12,300
-57% -$249K ﹤0.01% 594
2020
Q4
$333K Hold
21,700
0.01% 549
2020
Q3
$262K Hold
21,700
0.01% 546
2020
Q2
$221K Hold
21,700
0.01% 547
2020
Q1
$226K Hold
21,700
0.01% 515
2019
Q4
$347K Hold
21,700
0.01% 518
2019
Q3
$400K Hold
21,700
0.01% 544
2019
Q2
$427K Buy
21,700
+5,900
+37% +$120K 0.01% 518
2019
Q1
$361K Buy
15,800
+5,500
+53% +$119K 0.01% 525
2018
Q4
$207K Hold
10,300
0.01% 556
2018
Q3
$224K Buy
+10,300
New +$229K ﹤0.01% 582

Other funds holding ANGO

South Dakota Investment Council's ANGO Position: Q3 2021 in Review

South Dakota Investment Council sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 400 shares — an estimated $11K sold.

South Dakota Investment Council first reported a position in ANGO in Q3 2018 and held it in 12 quarters. The position peaked at $427K in Q2 2019. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

  • South Dakota Investment Council reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
  • South Dakota Investment Council sold 400 AngioDynamics shares in Q3 2021, an estimated $11K.
  • South Dakota Investment Council first reported a position in AngioDynamics in Q3 2018 and held it in 12 quarters.
  • South Dakota Investment Council's AngioDynamics position peaked at $427K in Q2 2019.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on South Dakota Investment Council's 13F filing for Q3 2021, filed 9 Nov 2021.